1. Home
  2. ENTX vs GAIA Comparison

ENTX vs GAIA Comparison

Compare ENTX & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.18

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.35

Market Cap

70.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
GAIA
Founded
2010
1988
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
70.9M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
ENTX
GAIA
Price
$1.18
$2.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$6.50
AVG Volume (30 Days)
85.4K
85.5K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
0.07
N/A
Revenue
$42,000.00
$4,500,000.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$12.04
P/E Ratio
$17.43
N/A
Revenue Growth
N/A
12.50
52 Week Low
$0.91
$2.23
52 Week High
$3.22
$6.39

Technical Indicators

Market Signals
Indicator
ENTX
GAIA
Relative Strength Index (RSI) 44.85 43.37
Support Level $1.07 $2.30
Resistance Level $1.37 $2.60
Average True Range (ATR) 0.07 0.12
MACD -0.01 0.01
Stochastic Oscillator 2.38 33.78

Price Performance

Historical Comparison
ENTX
GAIA

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

Share on Social Networks: